BERTIN-IT
5.6.2019 10:17:03 CEST | Business Wire | Press release
Bertin IT (CNIM Group) announces the release of the new version of MediaSpeech®, its multilingual speech recognition solution that converts audio tracks to searchable text transcripts, enabling audio and video sources, to be indexed searched and analysed. MediaSpeech® now also comes in a live version for real-time audio streams, paving the way for new interactive and augmented communications applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190605005384/en/
Thanks to deep neural networks commonly used in Artificial Intelligence systems, MediaSpeech® creates an extremely fine model of the acoustic space which is robust with different speakers and acoustic conditions, so offering even faster and more accurate transcription.
Features:
- Speech recognition with each word being transcribed within a millisecond and assigned a recognition confidence score .
- Automatic detection of spoken language (LID).
- Automatic segmentation speaking slots and speakers with gender recognition.
- Identification of the speaker from a biometric database.
- Automatic and semi-automatic adaptation of vocabularies and domains.
And all this in 17 different languages.
MediaSpeech® has several variations: deployed on site or in SaaS mode , hosted on Bertin IT’s cloud, MediaSpeech® Factory can handle large volumes of files with guaranteed performance levels ; a new version MediaSpeech® Live is able to transcribe audio streams on the fly, opening the door to innovative real-time applications - voice chatbots, call-bots, enhanced call centres (the enhanced call centre concept involves the provision of assistance to the adviser during the call so streamlining and improving the quality of the dialogue.).
Among the main improvements in the new version of MediaSpeech®:
- MediaSpeech® Live version for processing audio streams in real time.
- New neural models make transcription two to three times faster and more accurate.
- “Full" neuronal transition of all speech processing modules : speech detection (VAD) and speaker segmentation (Diarization) for even greater accuracy.
- Easy installation process , stronger security and new interfaces.
- A fully neuronal language identification module (LID) with increased accuracy , even for relatively short sections of speech.
Version 6 of MediaSpeech® is already being used by several customers, including a major French investment and finance bank. The MediaSpeech Live version has just been delivered to another major banking group for use at its contact centres.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190605005384/en/
Contact:
Nathalie Sablon nathalie.sablon@cnim.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus
Elliptic Announces Circle’s Participation in Agentic Design Partner Program9.7.2026 14:15:00 CEST | Press release
Following investment from Circle Ventures, the corporate venture arm of Circle Elliptic, the global leader in digital asset intelligence, today announced that an affiliate of Circle Internet Group, Inc. (‘Circle’) (NYSE:CRCL) has joined its Agentic Design Partner Program, bringing together infrastructure providers, compliance teams, and technology leaders to help shape compliance solutions for autonomous, AI-driven financial activity. This momentum follows an investment from Circle Ventures, the corporate venture arm of Circle, and builds on a longstanding collaboration between the companies. Circle has been an Elliptic customer for multiple years and has expanded its use of Elliptic’s compliance capabilities across a range of digital asset initiatives. As stablecoins, tokenized assets, and AI-powered applications become increasingly integrated into financial services, new compliance challenges are emerging. Elliptic’s agentic compliance layer addresses these challenges by combining un
Russell Investments Announces New Long-Term Owners9.7.2026 14:00:00 CEST | Press release
An investor consortium led by B Capital and including CalPERS will provide long-term capital to expandRussell Investments’ client capabilities and accelerate innovation Russell Investments, the global investment solutions provider, today announced that an investor consortium (the “Investor Consortium”) led by B Capital, a global multi-stage investment firm, and including California Public Employees' Retirement System ("CalPERS"), has agreed to acquire the firm from TA Associates (“TA”) and Reverence Capital Partners (“RCP”). The transaction comes as Russell Investments marks over $416 billion in global assets under management (AUM) and has experienced more than 15% organic growth over the past two years. Russell Investments has been a trusted, independent partner to its clients for over 90 years. Its open-architecture model delivers portfolio solutions that source from the full landscape of the asset management industry across public and private markets. With a shared vision for the co
Esri and Global Partners Release HydroSHEDS v2 for the Americas9.7.2026 14:00:00 CEST | Press release
Next-Generation Hydrographic Framework Delivers Unprecedented Detail for Watershed and River Network Analysis Esri and its global partners have released HydroSHEDS v2, providing high-resolution hydrographic data for North, Central, and South America. Developed with World Wildlife Fund in the US, McGill University and Confluvio Consulting in Canada, and the German Aerospace Center (DLR), the initiative reflects global collaboration in hydrologic science and geospatial technology. HydroSHEDS v2 leverages TanDEM-X elevation data and Arc Hydro workflows to deliver more accurate drainage networks, watershed boundaries, and hydrologic connectivity. The datasets support applications such as flood risk assessments, climate resilience studies, systematic conservation planning, water resource management, and environmental decision-making. HydroSHEDS v2 datasets are available through ArcGIS Living Atlas, with additional global releases planned as part of a phased rollout. Esri has made HydroSHEDS
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
